D-0431-2019 Class II Terminated

Recalled by Promise Pharmacy, LLC — Palm Harbor, FL

FDA drug recall D-0431-2019 was initiated by Promise Pharmacy, LLC on Dec 17, 2018 and is designated Class II. Reason for recall: Lack of sterility assurance. The recall status is terminated (terminated Mar 30, 2021). Affected quantity: 75 10 ml bottles.

Recall Details

Product Type
Drugs
Report Date
Feb 20, 2019
Initiation Date
Dec 17, 2018
Termination Date
Mar 30, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
75 10 ml bottles

Product Description

Acetylcysteine Ophthalmic Solution, 100mg/ml, 10%, Rx only, Promise Pharmacy Compounding Specialist, 31818 US Hwy 19N, Palm Harbor FL 34684.

Reason for Recall

Lack of sterility assurance.

Distribution Pattern

Nationwide in the USA.

Code Information

Lot: 11072018@10 BUD: 12/22/2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0431-2019
openFDA file date
Oct 21, 2026
Loaded by RegDataLab
Oct 23, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.